Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib
Sponsor: Fudan University